UGT1A1*28 gene polymorphism was not associated with the risk of neonatal hyperbilirubinemia: a meta-analysis.
Background: This study aimed to evaluate the relationship between UGT1A1 * 28 gene polymorphism and the risk of neonatal hyperbilirubinemia (NHBI). Methods: The studies meet certain selection condition were obtained from databases such as PubMed, Emabse and Cochrane Library. Newcastle-Ottawa Scale (NOS) was used to evaluate the quality of included studies. Meta-analysis was performed according to criteria such as country. Hardy-Weinberg equilibrium (HWE) tests were performed on the control group using chi-square test, while the evaluation index was represented by odds ratio (OR) and 95% confidence interval (CI). The Egger's test and sensitivity analysis was used to evaluate the publication bias and reliability, repetitively. Results: Totally four studies with high overall quality were enrolled in this study. No association was observed between UGT1A1*28 gene polymorphisms and NHBI in allele model (TA7 versus TA6, OR (95% CI) = 2.13 (0.81-5.62), p = 0.13), codominance models (TA7/6 versus TA6/6, OR (95% CI) = 2.94 (0.90-9.57), p = 0.07; TA7/7 versus TA6/6, OR (95% CI) = 2.08 (0.37-11.52), p = 0.40), recessive model (TA7/7 versus TA6/6 + TA7/6, OR (95% CI) = 1.44 (0.41-5.14), p = 0.57) and dominant model (TA7/7 + TA7/6 versus TA6/6, OR (95% CI) = 2.92 (0.84-10.12), p = 0.09). Furthermore, there was no publication bias was found in current meta-analysis. Conclusion: Gene polymorphism of UGT1A1*28 might not associated with the risk of NHBI.